The WHO report noted that five countries contributed to 56 percent of the worldwide TB cases—India (26 percent), Indonesia ...

India accounts for 30 per cent of the global TB burden and 62 per cent of multidrug-resistant cases. Despite a 17.7 per cent ...

The BPaLM regimen promises a breakthrough in MDR-TB treatment with a shorter, all-oral approach. However, high costs, limited ...

An equitable TB programme is one where every individual receives the highest quality of person-centred care that takes into ...

Govt launches 826 drug-resistant centers under the 100-day TB-Mukt Bharat Abhiyan to combat tuberculosis. Get the latest ...

Tuberculosis, an ongoing pandemic, highlights and exacerbates global disparities. With the prevailing model of standardised treatment in vertical health programmes, it is unsurprising that ...

Shortages of manpower and low expenditure made the implementation of NTEP deficient in the State of Andhra Pradesh, making ...

The NHS has issued a warning about the potential hazards of ibuprofen, advising those with certain symptoms such as a runny ...

Objective: This study aimed to assess the efficacy, safety and tolerability of oral moxifloxacin in patients with respiratory tract infections (RTIs) treated by attending physicians in routine ...

In adults and adolescents aged 14 years and older with rifampin-resistant, fluoroquinolone-susceptible pulmonary TB, the panel recommended a 6-month regimen consisting of bedaquiline, pretomanid, ...

Medically reviewed by Renee Nilan, MD Common antibiotics include penicillins, such as amoxicillin, and other types including ...